🇺🇸 besivance in United States

674 US adverse-event reports

Marketing authorisation

FDA

  • Status: approved

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Eye Pain — 119 reports (17.66%)
  2. Vision Blurred — 105 reports (15.58%)
  3. Off Label Use — 96 reports (14.24%)
  4. Eye Irritation — 89 reports (13.2%)
  5. Ocular Hyperaemia — 70 reports (10.39%)
  6. Chronic Kidney Disease — 43 reports (6.38%)
  7. Drug Ineffective — 40 reports (5.93%)
  8. Impaired Healing — 39 reports (5.79%)
  9. Foreign Body Sensation In Eyes — 37 reports (5.49%)
  10. Photophobia — 36 reports (5.34%)

Source database →

besivance in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Infectious Disease approved in United States

Frequently asked questions

Is besivance approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for besivance in United States?

Ophthalmology Consultants, Ltd. is the originator. The local marketing authorisation holder may differ — check the official source linked above.